SCHEMBL12397153

SCHEMBL12397153

Cc1nc(N)c2ncc([C@]3(C#N)O[C@H](COP(=O)(NCc4ccccc4)OCCSC(=O)C(C)(C)CO)[C@@H](O)[C@@]3(C)F)n2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18214612 0.95 — —
SCHEMBL12761526 0.94 — —
SCHEMBL12393479 0.94 — —
SCHEMBL12393317 0.89 — —
SCHEMBL10148712 0.86 — —
SCHEMBL10149732 0.85 — —
SCHEMBL10148662 0.83 — —
SCHEMBL14996129 0.81 — —
SCHEMBL19997409 0.79 — —
SCHEMBL19997412 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973013-B2 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC. (US) 2011-07-05 — — US disclosed
US-20110070194-A1 2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2011-03-24 — — US disclosed
Send feedback